Jennifer Whangbo, MD, PhD
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor, Harvard Medical School
Image
Jennifer Whangbo, MD, PhD
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Bachelor of Science
University of North Carolina
Chapel Hill
NC
Graduate School
Biological Sciences
University of California, San Francisco
San Francisco
CA
Medical School
University of California, Los Angeles
Los Angeles
CA
Internship
Pediatrics
Boston Children's Hospital/Boston Medical Center
Boston
MA
Residency
Pediatrics
Boston Children's Hospital/Boston Medical Center
Boston
MA
Fellowship
Pediatric Hematology -Oncology
Boston Children's Hospital/Dana-Farber Cancer Institute
Certifications
American Board of Pediatrics (General)
Publications
The dynamics of hematopoiesis over the human lifespan. View Abstract
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. View Abstract
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment. View Abstract
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation. View Abstract
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. View Abstract
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. View Abstract
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. View Abstract
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease. View Abstract
Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease. View Abstract
Tandem hematopoietic stem cell transplant considerations in families with multiple siblings affected by DOCK8 deficiency. View Abstract
Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease. View Abstract
Inefficiency of two-stage designs in phase II oncology clinical trials with high proportion of inevaluable patients. View Abstract
Comparison of Pulmonary Toxicity after Total Body Irradiation- and Busulfan-Based Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients. View Abstract
Genetic diagnosis of immune dysregulation can lead to targeted therapy for interstitial lung disease: A case series and single center approach. View Abstract
Spontaneous resolution of severe idiopathic T cell lymphopenia. View Abstract
Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation. View Abstract
Hematopoietic Stem Cell Transplantation Is a Curative Therapy for Transferrin Receptor 1 (TFRC) Deficiency. View Abstract
The role of regulatory T cells in graft-versus-host disease management. View Abstract
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children. View Abstract
TGFß signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond Syndrome. View Abstract
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease. View Abstract
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease. View Abstract
Clinical Metabolomics Identifies Blood Serum Branched Chain Amino Acids as Potential Predictive Biomarkers for Chronic Graft vs. Host Disease. View Abstract
Immunologic reconstitution following hematopoietic stem cell transplantation despite lymph node paucity in NF-?B-inducing kinase deficiency. View Abstract
B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation. View Abstract
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. View Abstract
SID-1 Domains Important for dsRNA Import in Caenorhabditis elegans. View Abstract
Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1. View Abstract
Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells. View Abstract
Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. View Abstract
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease. View Abstract
Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD. View Abstract
Apoptosis Triggers Specific, Rapid, and Global mRNA Decay with 3' Uridylated Intermediates Degraded by DIS3L2. View Abstract
Leukocyte protease binding to nucleic acids promotes nuclear localization and cleavage of nucleic acid binding proteins. View Abstract
Environmental RNA interference. View Abstract
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. View Abstract
Identification of genes that regulate a left-right asymmetric neuronal migration in Caenorhabditis elegans. View Abstract
Multiple levels of regulation specify the polarity of an asymmetric cell division in C. elegans. View Abstract
A Wnt signaling system that specifies two patterns of cell migration in C. elegans. View Abstract
A Wnt signaling pathway controls hox gene expression and neuroblast migration in C. elegans. View Abstract